31 December 2021 — Swiss Policy Research
Omicron: 54% fewer hospitalizations and deaths compared to delta (Ontario)
Fewer severe cases, vaccine failure, rapid spread, murky origins.
Data from South Africa indicated that the impact of the omicron wave was much lower than previous covid. However, South Africa had already a total infection rate of about 80%, indcluding about 200,000 covid deaths in 60 million people, i.e. a population fatality rate of about 0.3%.
Thus, it was not immediately clear if the lower impact in South Africa was due to prior immunity or lower intrinsic virulence of the omicron variant. Early data from Europe remained ambiguous, too, as omicron primarily affected young people and travelers.
But recent data from Denmark, Norway, Britain and Canada, although still preliminary, appear to show that omicron really causes fewer severe cases of covid, regardless of vaccination and immunity status.
For instance, a preprint study from Ontario with about 15,000 people found that the risk of hospitalization or death was about 50% lower among omicron cases compared to delta cases (see chart above; the 95% confidence interval ranges from 25% to 75%).
The latest official data from Denmark also shows a ~50% lower hospitalization rate with omicron compared to delta (1.1% vs. 0.6%). An analysis by Imperial College London estimates that the hospitalization rate of omicron is about 25% to 50% lower compared to delta.
The somewhat lower virulence of omicron will be especially important for people at high risk of severe covid, whereas the general population may not notice much of a difference. Indeed, case studies of (vaccinated) omicron outpatients describe symptoms very similar to previous coronavirus variants, including chest pain or shortness of breath in 20% to 40% of cases (see “7 boosted Germans go to South Africa” (table 2) and “33 boosted nurses have a party in the Faroe islands” (table 1)).
Omicron in South Africa:
Omicron in South Africa (FT)
Why is omicron milder?
Preliminary cell culture studies and animal studies show that, while omicron achieves very high viral loads in the upper airways – explaining its rapid spread and short incubation period –, it appears to achieve lower viral loads in the lungs. In addition, omicron appears to induce much less cell fusion, thus causing less tissue damage.
Omicron: Lower viral load in the lungs and lower cell fusion:
Omicron: Less cell fusion
Omicron: Less lung tissue damage in hamsters
Several studies have shown that existing covid vaccines, which are still based on the original Wuhan coronavirus strain, achieve almost no neutralization against omicron. Protection against infection, even after a booster, appears to be 30% to 50% at most and is waning within weeks.
In many countries, infection rates among vaccinated people are currently higher than among unvaccinated people, perhaps because there are already more recovered people among the unvaccinated people, or because recently vaccinated/boosted people have a higher infection risk (post-vaccination spike in infection risk).
At any rate, vaccination provides no longer any meaningful protection against infection with omicron, and “vaccine passports” have become entirely useless or counterproductive.
There are some indications that vaccination still provides some protection against severe disease; it has been argued that this might be due to a broader T cell response or immune memory. Previous infection also provides good protection (50%-60%) against severe disease, but it can no longer prevent reinfection (i.e. many previously infected people will get re-infected).
On the positive side, there are first antibody neutralization results showing that an infection with omicron provides protection against the delta variant, too.
Vaccines: Zero protection after 45-90 days, negative after >90 days.
Vaccines: Zero protection after 45-90 days, negative after >90 days. (Denmark)
Omicron has already taken over from delta in parts of Europe and the US, or is currently in the process of doing so. In many countries, and also at the global level, coronavirus infections have reached a new all-time record.
Despite a hospitalization rate that is 25% to 50% lower (see above), omicron has already significantly increased hospital and ICU admissions and even deaths in places like Denmark, England and New York City (see next charts). It is true that some of these hospitalization are not “due to covid”, but in-hospital transmission is not a positive thing, either.
Therefore, early treatment of high-risk patients should remain a top priority.
At the global level, a clock-like 120-day coronavirus infection cycle has been observed in the last two years; the current global cycle should peak around January 3, but it is also possible that omicron will break this cycle and continue its expansion.
Denmark (cases, hospital admissions, ICU patients, deaths):
Omicron in Denmark (OWD)
England (hospital admissions):
Omicron in England (Covid Actuary)
New York City (hospital and ICU patients):
New York City (hospital and ICU patients) (New York)
Omicron in Australia (Ian MSC)
The origins of the omicron variant, probably in South Africa, remain very murky. First, the last known ancestor of omicron dates back to March-June 2020 (!). Second, the extreme imbalance between synonymous and non-synonymous mutations (non-changing vs. changing amino acids) indicates an unnatural origin (i.e. not via evolution, not even in mice).
This currently points to either some lab experiment (e.g. during vaccine development or immune escape research, which was performed in some South African labs), or possibly to a mutation induced during the molnupiravir drug trial in South Africa (i.e. the Merck pill that induces a very high rate of mutations).
Meanwhile, Taiwan confirmed that in late November, a scientist in a BSL-3 lab got infected by the delta variant of the coronavirus during lab work.